NEOG

+ Watchlist + Portfolio

Neogen Corp.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $12.15
52-Week Range: $4.90 – $12.85
Market Cap: $2.58B
P/E (TTM): —
EPS (TTM): -0.04
Dividend Yield: —

Advanced Metrics

Price/Book: 1.23
PEG Ratio: 0.66
Return on Equity: -0.38%
Return on Assets: -0.40%
Gross Margin: 46.93%
Operating Margin: 1.38%
Profit Margin: -0.91%
Current Ratio: 3.82
Debt/Equity: 0.39
Total Debt: $812.60M
Free Cash Flow: $69.50M
Revenue Growth: -0.10%
Earnings Growth: —
Enterprise Value: $3.28B

NEOG Income statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Revenue	$822.45M	$924.20M	$894.70M	$870.40M
Cost of Revenue	$416.49M	$460.30M	$473.30M	$461.90M
Gross Profit	$405.95M	$463.90M	$421.40M	$408.50M
Research & Development	$26.04M	$22.50M	$21.10M	$18.40M
Selling, General & Admin	$342.40M	$382.80M	$402.00M	$411.70M
Operating Expenses	$368.44M	$405.30M	$423.10M	$430.10M
Operating Income	$37.52M	$58.60M	-$1.70M	-$21.60M
EBITDA	$124.39M	$173.90M	-$938.90M	$170.50M
Pretax Income	-$22.04M	-$14.30M	-$1.13B	-$9.00M
Income Tax	$828.00K	-$4.90M	-$41.10M	-$1.10M
Net Income	-$22.87M	-$9.40M	-$1.09B	-$7.90M
Diluted EPS	-0.12	-0.04	-5.03	-0.04
Diluted Shares	216.25M	216.61M	217.04M	217.50M

NEOG Balance Sheet statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Cash & Equivalents	$163.24M	$170.61M	$129.00M	$185.50M
Receivables	$153.25M	$173.00M	$153.40M	$146.80M
Inventory	$133.81M	$189.27M	$190.80M	$144.30M
Current Assets	$585.93M	$589.23M	$576.90M	$604.60M
Total Assets	$4.55B	$4.55B	$3.44B	$3.35B
Current Liabilities	$145.47M	$154.32M	$174.00M	$158.20M
Long-Term Debt	$885.44M	$888.39M	$874.80M	$793.70M
Total Debt	$885.44M	$890.84M	$894.10M	$793.70M
Total Liabilities	$1.42B	$1.40B	$1.37B	$1.25B
Retained Earnings	$565.04M	$555.62M	-$536.40M	-$544.30M
Shareholders' Equity	$3.13B	$3.14B	$2.07B	$2.09B
Working Capital	$440.46M	$434.91M	$402.90M	$446.40M
Net Debt	$722.20M	$720.23M	$765.10M	$608.20M

NEOG Cash Flow statement, annual periods, in USD
USD	FY2023	FY2024	FY2025	FY2026
Operating Cash Flow	$41.03M	$35.30M	$58.20M	$83.20M
Capital Expenditure	-$65.76M	-$111.40M	-$104.60M	-$51.30M
Free Cash Flow	-$24.73M	-$76.10M	-$46.40M	$31.90M
Depreciation & Amortisation	$90.47M	$121.20M	$125.70M	$121.90M
Stock-Based Compensation	$10.18M	$13.80M	$17.30M	$13.40M
Investing Cash Flow	$201.04M	-$29.30M	-$99.20M	$70.50M
Financing Cash Flow	-$118.08M	$1.90M	-$1.60M	-$99.40M
Net Change in Cash	$123.99M	$7.90M	-$42.60M	$54.30M

NEOG Income statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$225.46M	$209.19M	$224.69M	$211.20M	$225.30M
Cost of Revenue	$132.60M	$114.22M	$118.01M	$112.20M	$117.50M
Gross Profit	$92.86M	$94.97M	$106.68M	$99.00M	$107.80M
Research & Development	$6.31M	$5.13M	$4.56M	$3.80M	$4.90M
Selling, General & Admin	$99.80M	$105.94M	$107.50M	$98.50M	$99.80M
Operating Expenses	$106.11M	$111.06M	$112.06M	$102.30M	$104.70M
Operating Income	-$13.25M	-$16.09M	-$5.38M	-$3.30M	$3.10M
EBITDA	-$577.62M	$89.31M	$23.41M	$22.52M	$36.80M
Pretax Income	-$631.20M	$43.81M	-$20.36M	-$20.30M	-$12.10M
Income Tax	-$19.01M	$7.47M	-$4.44M	-$3.30M	-$800.00K
Net Income	-$612.20M	$36.34M	-$15.92M	-$17.00M	-$11.30M
Diluted EPS	-2.82	0.17	-0.07	-0.08	-0.05
Diluted Shares	217.04M	217.33M	217.53M	217.70M	217.70M

NEOG Balance Sheet statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$129.00M	$138.88M	$145.34M	$159.90M	$185.50M
Receivables	$153.40M	$138.46M	$132.00M	$137.10M	$146.80M
Inventory	$190.80M	$193.41M	$162.77M	$161.70M	$144.30M
Current Assets	$576.90M	$524.06M	$574.58M	$590.00M	$604.60M
Total Assets	$3.44B	$3.38B	$3.36B	$3.36B	$3.35B
Current Liabilities	$174.00M	$146.21M	$147.05M	$150.60M	$158.20M
Long-Term Debt	$874.80M	$792.53M	$792.93M	$793.30M	$793.70M
Total Debt	$894.10M	$792.53M	$792.93M	$793.30M	$793.70M
Total Liabilities	$1.37B	$1.26B	$1.26B	$1.26B	$1.25B
Retained Earnings	-$536.40M	-$500.09M	-$516.01M	-$533.00M	-$544.30M
Shareholders' Equity	$2.07B	$2.12B	$2.10B	$2.10B	$2.09B
Working Capital	$402.90M	$377.86M	$427.53M	$439.40M	$446.40M
Net Debt	$765.10M	$653.65M	$647.59M	$633.40M	$608.20M

NEOG Cash Flow statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$16.54M	$10.85M	$19.44M	$22.70M	$30.20M
Capital Expenditure	-$16.14M	-$24.00M	-$11.67M	-$11.63M	-$4.00M
Free Cash Flow	$406.00K	-$13.15M	$7.78M	$11.07M	$26.20M
Depreciation & Amortisation	$36.45M	$29.05M	$28.93M	$28.92M	$35.00M
Stock-Based Compensation	$4.33M	$4.96M	$4.34M	$1.10M	$3.00M
Investing Cash Flow	-$15.93M	$97.72M	-$11.67M	-$11.56M	-$4.00M
Financing Cash Flow	-$2.11M	-$99.39M	-$451.00K	$744.00K	-$300.00K
Net Change in Cash	-$1.50M	$9.19M	$7.32M	$11.89M	$25.90M

Market Snapshot

About

Neogen Corp. develops and markets food and animal safety testing products. The company provides diagnostic test kits, dehydrated culture media, disinfectants, and genomic solutions for food processors, veterinarians, and agricultural producers.